GeneLink distribution deal
This article was originally published in The Tan Sheet
Executive Summary
Start-up direct marketer NuGenix expects to begin selling customized nutritional products developed using GeneLink technology in Q3. Under distribution agreement announced May 8, NuGenix will use GeneLink's patented DNA Collection Kit and nutragenetic assessment system to provide its network of distributors with a customized nutritional regimen consisting initially of approximately six formulas; supplements will be developed and manufactured by Vitaquest division Garden State Nutritionals (1"The Tan Sheet" Oct. 8, 2001, p. 14). Philadelphia-based NuGenix is hoping to attract distributors from other direct marketers both inside and outside the supplement industry...
You may also be interested in...
Genetic Technology Enters Supplement Industry With GSN, GeneLink Deal
Garden State Nutritionals will offer five dietary supplements tailored for consumers' varying genetic capacities to combat certain types and degrees of oxidative stress, according to the firm.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.